Duration of Heparin's Anticoagulant Effect
The anticoagulant effect of intravenous heparin lasts approximately 60-90 minutes after discontinuation, with a half-life of 60-90 minutes, while subcutaneous heparin's effect is delayed by 1-2 hours and peaks at 3 hours after administration. 1, 2
Pharmacokinetics of Heparin
Intravenous Administration
- Half-life: 60-90 minutes (varies with dose)
- At low doses (25 units/kg): ~30 minutes
- At standard therapeutic doses (100 units/kg): ~60 minutes
- At high doses (400 units/kg): ~150 minutes 2
- Onset of action: Immediate
- Duration of effect: Effects diminish within 60-90 minutes after stopping infusion
Subcutaneous Administration
- Onset of action: Delayed for 1-2 hours
- Peak effect: Occurs approximately 3 hours after injection
- Bioavailability:
Factors Affecting Heparin Duration
Clearance Mechanisms
Heparin is cleared through two primary mechanisms:
Rapid saturable mechanism:
- Binding to endothelial cell receptors and macrophages
- Dose-dependent and predominant at therapeutic doses
- Results in depolymerization of the heparin molecule
Slower first-order mechanism:
Patient-Specific Factors
- Pulmonary embolism: Significantly shortened half-life (demonstrated in studies showing half-life of ~63 minutes in most patients vs. significantly shorter in those with PE) 4
- Weight: Affects volume of distribution and clearance
- Renal function: Impacts the slower clearance mechanism
- Binding proteins: Variable levels of heparin-binding proteins affect anticoagulant response 2
Clinical Implications
Monitoring Requirements
- First aPTT measurement: 6 hours after bolus dose
- Subsequent monitoring:
Transitioning Between Anticoagulants
- When transitioning to oral anticoagulants:
- Allow at least 5 hours after the last IV heparin dose before drawing blood for prothrombin time
- Allow 24 hours after the last subcutaneous dose 6
- Overlap with warfarin for 4-5 days until INR is therapeutic (2.0-3.0) for 2 consecutive days 5
Common Pitfalls
- Inadequate monitoring: Failure to achieve therapeutic aPTT within 24 hours is associated with increased risk of recurrent thromboembolism
- Rebound effect: Abrupt discontinuation may lead to rebound hypercoagulability in some patients
- Variable response: Inter-individual variations in heparin clearance and response necessitate individualized monitoring
- Drug interactions: Medications like nitroglycerin can decrease aPTT with subsequent rebound upon discontinuation 6
Remember that the pharmacokinetics of heparin are nonlinear at therapeutic doses, with both intensity and duration of effect rising disproportionately with increasing doses due to the saturable clearance mechanism 2, 3.